Just as large pharma companies prepare a showdown with Medicare's newfound power to negotiate down drug prices, several major drug companies are reportedly gearing up to implement price increases on more than 500 drugs in the U.S. in early January.
Companies including Pfizer Inc (NYSE: PFE), Sanofi SA (NASDAQ: SNY), and Takeda Pharmaceutical Co Ltd (NYSE: TAK) are expected to participate in the move that comes as part of the pharmaceutical industry's preparation for the forthcoming publication of significantly discounted prices for ten high-cost drugs by ...